Clinical Trial Update: Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of DM-CHOC-PEN for brain tumors has completed; results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Malignant Neoplasm to Brain

Drugs mentioned

• DM-CHOC-PEN (4-Demethyl-4-cholesteryloxycarbonylpenclome)

Snippet

Sponsor: DEKK-TEC, Inc. | Conditions: Primary Brain Tumors, Metastatic Malignant Neoplasm to Brain | Phase 2 | Status: COMPLETED | Results posted: 2020-09-16